Screener
Haemonetics HAE Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The source filing: Haemonetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:09 AM EDT
- Fiscal quarter
- Q1 FY2027
- Calendar quarter
- Q2 2026
- Accession
- 0000313143-26-000120
| Line item | June 27, 2026 | March 28, 2026 |
|---|---|---|
| Current liabilities: | ||
| Notes payable and current maturities of long-term debt | $4,956 | $5,015 |
| Accounts payable | 56,338 | 51,056 |
| Accrued payroll and related costs | 38,145 | 68,191 |
| Other current liabilities | 163,796 | 158,337 |
| Total current liabilities | 263,235 | 282,599 |
| Long-term debt | 1,169,202 | 1,219,565 |
| Deferred tax liability | 38,691 | 38,048 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Haemonetics's accrued expenses?
- Haemonetics (HAE) reported accrued expenses of $38.15M in Q2 2026.
- How has Haemonetics's accrued expenses changed year-over-year?
- Haemonetics's accrued expenses increased by 6.5% year-over-year, from $35.81M to $38.15M.
- What is the long-term trend for Haemonetics's accrued expenses?
- Over 5 years (2021 to 2026), Haemonetics's accrued expenses has grown at a 7.5% compound annual growth rate (CAGR), from $47.6M to $68.19M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.
Ask your AI about Haemonetics's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude